IP Library › Granted Patent US 12,674,160
Granted Patent B2
US 12,674,160 · App. 17/961,205 · Granted Jul 7, 2026

Stabilization of RNA for exogenous RNAi agricultural applications and formulations

Inventors: William Stewart (Durham, NC); Lorenzo Aulisa (Chesterfield, MO); David Villiard (Medford, MA); Jason Gillian (Durham, NC); Kayla Owens (Youngsville, NC); Namita Dodwadkar (North Reading, MA); Paul Boucher (Medford, MA); Justin Eldridge (Wilson, NC)
Assignee: GREENLIGHT BIOSCIENCES, INC.
C12N15/113A01N25/02A01N25/22A01N25/30C11D1/94
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,160
App. No.
17/961,205
Filed
Oct 6, 2022
Granted
Jul 7, 2026
Kind
B2
Art Unit
1617
USPC
514/44A
Abstract

Compositions for providing stability to RNA may include a primary surfactant, and a metal-ion sequestrant. The primary surfactant may be a nonionic surfactant. The composition may be in a soluble liquid concentrate form and may be sufficient to provide shelf stability to RNA for one year at room temperature. Compositions for delivering RNA to a pest via exogenous, foliar application of the composition to a plant may comprise RNA; a primary surfactant; and a metal-ion sequestrant.

Claims (35)

1 . A composition for delivering RNA to a pest via exogenous, foliar application of the composition to a plant, the composition comprising:

RNA, wherein the RNA is present in an amount from about 0.4 to about 10 percent by weight based on the total weight of the composition;

a primary surfactant, wherein the primary surfactant is a nonionic surfactant, where in the primary surfactant is present in an amount of from about 4 to about 7 percent by weight based on the total weight of the composition;

a secondary surfactant, wherein the secondary surfactant is selected from the group consisting of a cationic surfactant, a zwitterionic surfactant, an amphoteric surfactant, and combinations thereof, wherein the secondary surfactant is present in an amount of from about 0.5 to about 3 percent by weight based on the total weight of the composition; and

a metal-ion sequestrant, wherein the metal-ion sequestrant is present in an amount of from about 0.6 to about 3 percent by weight based on the total weight of the composition;

and wherein the RNA is dsRNA or single-stranded RNA; and

wherein the composition controls a plant pest or pathogen selected from the group consisting of an insect or a fungus.

2 . The composition according to claim 1 , wherein the composition is a soluble liquid concentrate.

3 . The composition according to claim 1 , further comprising one or more of the following:

a UV protectant;

at least one buffer;

at least one biological preservative;

an antifoam agent; and/or

an antifreeze agent.

4 . The composition according to claim 3 , wherein the composition comprises the UV protectant, the UV protectant being present in an amount of from about 1 to about 15 percent by weight based on the total weight of the composition, or optionally, being present in an amount of from about 1 to about 2 percent by weight based on the total weight of the composition.

5 . The composition according to claim 3 , wherein the composition comprises the UV protectant, the UV protectant comprising a UV protectant selected from the group consisting of conjugated aromatic surfactant or a polymeric surfactant containing conjugated aromatic functionalities.

6 . The composition according to claim 3 , wherein the composition comprises the UV protectant, the UV protectant comprising a sodium lignosulfonate dispersant.

7 . The composition according to claim 3 , wherein the composition comprises the at least one buffer, the at least one buffer being individually present in an amount of from about 1 to about 7 percent by weight based on the total weight of the composition, or optionally, the at least one buffer being present in an amount of from about 2 to about 5 percent by weight based on the total weight of the composition.

8 . The composition according to claim 3 , wherein the composition comprises the at least one buffer, the at least one buffer comprising monobasic potassium phosphate and dibasic potassium phosphate.

9 . The composition according to claim 3 , wherein the composition comprises the at least one biological preservative, the at least one biological preservative comprising a an active ingredient selected from the group consisting of 5-chloro-2-methyl-4-isothiazolin-3-one (CMIT), 2-methyl-4-isothiazolin-3-one (MIT), 1,2-Benzisothiazolin-3-one (BIT), and combinations thereof.

10 . The composition according to claim 3 , wherein the composition comprises the at least one biological preservative, the at least one biological preservative being individually present in an amount of from about 0.05 to about 1 percent by weight based on the total weight of the composition.

11 . The composition according to claim 3 , wherein the composition comprises the antifoam agent, the antifoam agent being present in an amount of from about 0.025 to about 0.2 percent by weight based on the total weight of the composition, or optionally, the antifoam agent being present in an amount of from about 0.025 to about 0.1 percent by weight based on the total weight of the composition.

12 . The composition according to claim 1 , wherein the primary surfactant is selected from the group consisting of a polysorbate, an alkoxylate, a nonoxynol, a poloxamer, and combinations thereof.

13 . The composition according to claim 1 , wherein the primary surfactant is selected from the group consisting of polysorbate 20, an alkoxylated alcohol, and an alkoxylate mixture of C 12 -C 13 alcohol.

14 . The composition claim 1 , wherein the metal-ion sequestrant is present in an amount of from about 1 to about 2 percent by weight based on the total weight of the composition.

15 . The composition according to claim 1 , wherein the metal-ion sequestrant is selected from the group consisting of EDTA and an acrylate copolymer.

16 . The composition of claim 15 , wherein the metal-ion sequestrant is an acrylate copolymer.

17 . The composition according to claim 1 , wherein the secondary surfactant is present in an amount of from about 0.7 to about 2 percent by weight based on the total weight of the composition.

18 . The composition according to claim 17 , wherein the secondary surfactant is present in an amount of from about 0.8 to about 1 percent by weight based on the total weight of the composition.

19 . The composition according to claim 1 , wherein the secondary surfactant is selected from the group consisting of an alkyl ammonium halide, lauryl betaine, an amine oxide, and combinations thereof.

20 . The composition according to claim 19 , wherein the secondary surfactant comprises cetrimonium chloride.

21 . The composition of claim 1 , wherein the composition is sufficient to provide shelf stability to RNA for one year at room temperature.

22 . The composition of claim 1 , wherein, the pH of the composition remains within 2 units of the initial pH after the composition is stored for a time at a temperature selected from the group consisting of 2 weeks at −20° C., 2 weeks at −10-40° C., cycling, 2 weeks at 54° C., 8 weeks at 40° C., 4 weeks at 54° C., 8 weeks at 54° C., 1 year at room temperature, and 2 years at room temperature.

23 . The composition of claim 1 , wherein the RNA present in the composition remains within 15% of the initial concentration of RNA present in the composition as measured by HPLC, after the composition is stored for a time and at a temperature selected from the group consisting of 2 weeks at −20° C., 2 weeks at −10-40° C., cycling, 2 weeks at 54° C., 8 weeks at 40° C., 4 weeks at 54° C., 8 weeks at 54° C., 1 year at room temperature, and 2 years at room temperature.

24 . The composition of claim 1 wherein the RNA is dsRNA.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: AULISA, LORENZO
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065436/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: BOUCHER, PAUL
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065436/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: DODWADKAR, NAMITA
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065436/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: ELDRIDGE, JUSTIN
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065436/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: VILLIARD, DAVID; GILLIAN, JASON
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065437/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: OWENS, KAYLA
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065437/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: STEWART, WILLIAM
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 065437/0156 →
Continuity (3)
Continuation 17737426 · May 5, 2022
Provisional Application 63184508 · May 5, 2021
Related Publication 20230106660A1 · Apr 6, 2023
References Cited (25)
US 10858385B2 · Cunningham et al. · 2020 [cited by applicant]
US 10954541B2 · Blake et al. · 2021 [cited by applicant]
US 11142768B2 · Barros Rodrigues et al. · 2021 [cited by applicant]
US 11185079B2 · Barros Rodrigues et al. · 2021 [cited by applicant]
US 20110033842A1 · Moon et al. · 2011 [cited by applicant]
US 20180237790A1 · Maori · 2018 [cited by examiner]
US 20180360030A1 · Morgenstern · 2018 [cited by examiner]
CN 102424821 · 2012 [cited by examiner]
CN 102424821A · 2012 [cited by applicant]
CN 103109800 · 2013 [cited by applicant]
WO 20100147933A1 · 2010 [cited by applicant]
WO 2016018887A1 · 2016 [cited by applicant]
WO 2016073732A1 · 2016 [cited by applicant]
WO 2020041782A1 · 2020 [cited by applicant]
WO 2020102570A1 · 2020 [cited by applicant]
WO 2020123419A2 · 2020 [cited by applicant]
WO 20210204594A1 · 2021 [cited by applicant]
WO 2021231791A2 · 2021 [cited by applicant]
PCT Search Report & Written Opinion, PCT/US2022/027816, mailed Sep. 1, 2022, 9 pages. [cited by applicant]
Ghildiyal, Megha et al., “Small silencing RNAs: an expanding universe”, Nat Rev Genet., Feb. 2009, vol. 10, No. 1, pp. 94-108. [cited by applicant]
EESR, EP22799571.9-1102/4333623 PCT/US2022027816, mailed Feb. 25, 2025, 11 pages. [cited by applicant]
INAPI, Chile No. 2023-03261 , PCT/2023-03261, mailed Jul. 4, 2025, 18 pages. [cited by applicant]
Bennett, et al. Barriers to efficient foliar uptake of dsRNA and molecular barriers to dsRNA activity in plant cells. Fronteras in Plant Science, 11:816. (2020). [cited by applicant]
Morozov, et al. Double-Stranded RNAs in plant protection against pathogenic organisms and viruses in agriculture. ActaNaturae, 11:13-21. (2019). [cited by applicant]
CL Office Action mailed Apr. 6, 2026 18 pages English portions only. [cited by applicant]